Your browser doesn't support javascript.
loading
Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.
Rengarajan, Sunaina; Vivio, Emily E; Parkes, Miles; Peterson, Daniel A; Roberson, Elisha D O; Newberry, Rodney D; Ciorba, Matthew A; Hsieh, Chyi-Song.
Afiliación
  • Rengarajan S; Division of Rheumatology, Department of Internal Medicine, Washington University School of Medicine , St. Louis, MO USA.
  • Vivio EE; IBD Program, Division of Gastroenterology, Department of Internal Medicine, Washington University School of Medicine , Saint Louis, MO, USA.
  • Parkes M; Division of Gastroenterology, Addenbrooke's Hospital and Department of Medicine, University of Cambridge , Cambridge, UK.
  • Peterson DA; Eli Lilly and Co , Indianapolis, IN, USA.
  • Roberson EDO; Division of Rheumatology, Department of Internal Medicine, Washington University School of Medicine , St. Louis, MO USA.
  • Newberry RD; IBD Program, Division of Gastroenterology, Department of Internal Medicine, Washington University School of Medicine , Saint Louis, MO, USA.
  • Ciorba MA; IBD Program, Division of Gastroenterology, Department of Internal Medicine, Washington University School of Medicine , Saint Louis, MO, USA.
  • Hsieh CS; Division of Rheumatology, Department of Internal Medicine, Washington University School of Medicine , St. Louis, MO USA.
Gut Microbes ; 11(3): 405-420, 2020 05 03.
Article en En | MEDLINE | ID: mdl-31203722
Aberrant immune responses against gut microbiota are thought to be key drivers of inflammatory bowel disease (IBD) pathogenesis. However, the extent and targets of immunoglobulin (Ig) A versus IgG responses to gut bacteria in IBD and its association with IBD severity is not well understood. Here, we address this by analyzing fecal samples from Crohn's disease (CD), ulcerative colitis (UC), and Non-IBD patients by flow cytometry for the frequency of bacteria that were endogenously bound with IgA and/or IgG. Assessment of IBD patients from two geographically distinct cohorts revealed increased percentages of IgA- and IgG-bound fecal bacteria compared to non-IBD controls. Notably, the two major subsets of IBD showed distinct patterns of Ig-bound bacteria, with CD activity associated with increases in both IgA and IgG-bound bacteria, whereas UC activity correlated only with increases in IgG-bound bacteria. Analysis of the flow sorted Ig-bound bacterial repertoire by 16S rDNA sequencing revealed taxa that were Ig-bound specifically in IBD. Notably, this included bacteria that are also thought to reside in the oral pharynx, including Gemella, Peptostreptococcus, and Streptococcus species. These data show that the pattern of IgA and IgG binding to fecal bacteria is distinct in UC and CD. In addition, the frequency of Ig-bound fecal bacteria may have potential as a non-invasive biomarker for disease activity. Finally, our results support the hypothesis that immune responses to oral pharyngeal bacteria may play an important role in the pathogenesis of IBD.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Faringe / Inmunoglobulina A / Inmunoglobulina G / Enfermedades Inflamatorias del Intestino / Microbioma Gastrointestinal Límite: Humans Idioma: En Revista: Gut Microbes Año: 2020 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Faringe / Inmunoglobulina A / Inmunoglobulina G / Enfermedades Inflamatorias del Intestino / Microbioma Gastrointestinal Límite: Humans Idioma: En Revista: Gut Microbes Año: 2020 Tipo del documento: Article